BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Business

  Myriad Genetics, Inc. Reports Full-Year and Fiscal Fourth-Quarter 2013 Financial Results

  August 14, 2013

   · 

  1 min read
• Business

  TearLab Corporation Reports Q2-13 Financial Results

  August 14, 2013

   · 

  1 min read
• Business

  Elite Pharmaceuticals, Inc. Announces Fiscal Year 2014 First Quarter Conference Call on Thursday, August 15, 2013

  August 14, 2013

   · 

  1 min read
• BioCapital

  Intrexon Corporation Announces Closing of Initial Public Offering and Full Exercise of Over-Allotment Option by Underwriters

  August 14, 2013

   · 

  1 min read
• Business

  MYOS Reports Second Quarter 2013 Financial Results and Recent Key Operational Highlights

  August 14, 2013

   · 

  16 min read
• GW Pharmaceuticals Opens an Investigational New Drug Application (IND) in the United States for a Sativex® Phase 3 Clinical Program as a Treatment for Spasticity Due to Multiple Sclerosis

  August 14, 2013

   · 

  7 min read
• Business

  Bovie Medical Corporation Reports Results for Three and Six-Months Ended June 30, 2013

  August 14, 2013

   · 

  8 min read
• Drug Development

  Prima Biomed’s “CANVAS” Clinical Trial Approved to Start in Korea

  August 14, 2013

   · 

  2 min read
• Biotech Beach

  Organovo Cautions Investors in Regards to “Short and Distort” Articles

  August 14, 2013

   · 

  5 min read
• Deals

  Cubist Pharmaceuticals, Inc. Commences Tender Offer for All Outstanding Shares of Trius Therapeutics

  August 14, 2013

   · 

  1 min read